Navigation Links
Endo and Metamark Announce Sale of HealthTronics Laboratory Solutions
Date:8/12/2013

MALVERN, Pa. and CAMBRIDGE, Mass., Aug. 12, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that its wholly owned subsidiary, HealthTronics, Inc. has entered into a definitive agreement to sell its anatomical pathology business, HealthTronics Laboratory Solutions, Inc., ("HLS") to Metamark Genetics, Inc. ("Metamark") for an undisclosed amount.   As previously announced Endo Health Solutions is pursuing strategic alternatives for HealthTronics, Inc. and believes the sale of HLS creates progress in this process.  

Metamark is at the leading edge of research in cancer prognosis, which is a critical tool in determining appropriate cancer therapy. In the age of personalized medicine, particularly in oncology, Metamark's proprietary multiplex proteomic platform has the potential to reshape the landscape in cancer diagnosis and therapy.

HLS provides anatomical pathology services primarily to the urology community. The HLS pathology labs are located in Georgia and Pennsylvania and provide laboratory and diagnostic services to urologists throughout the U.S., with client practices in 41 states.  In addition, HLS manages pathology laboratories for physician practice groups, provides administrative services to in-office pathology labs for practice groups, and provides pathology services to physicians.

"HLS is a recognized national reference lab providing specialized pathology services to the urology community with a reputation for quality," said Shawn M. Marcell, president and CEO of Metamark Genetics. "We believe joining forces with HLS will be instrumental to our success as we commercialize ProMark™, Metamark's novel prostate cancer test."

Kelly Huang, PhD, President of HealthTronics, stated "Metamark has strong ambitions for growth, shares our commitment to improved patient outcomes, and is dedicated to continue to serve the needs of urologists and the patients for which they care."

About HealthTronics

HealthTronics has been a national provider of urological and interventional oncology services and products for more than 20 years. Headquartered in Austin, Texas, with anatomical pathology laboratories in three states, the company provides the most advanced technology and premiere support systems to urologists, interventional radiologists, hospitals, surgery centers and clinics across the United States. HealthTronics is an operating company of Endo Health Solutions Inc.

About Endo

Endo Health Solutions Inc. (Endo) is a U.S.-based specialty healthcare company with four distinct business segments that are focused on branded and generic pharmaceuticals, devices and services, each providing quality products to our customers while improving the lives of patients.  Through our operating companies – AMS, Endo Pharmaceuticals, HealthTronics and Qualitest – Endo is dedicated to finding solutions for the unmet needs of patients. Learn more at www.endo.com.

About Metamark

Metamark Genetics, Inc. ("Metamark") is a privately held biotechnology company founded in 2007 to develop new function-based prognostic and diagnostic tests aimed at improving cancer care.  The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon and breast cancers. During 2013, Metamark plans to commercialize ProMark™ – its lead prostate cancer prognostic test – through its Cambridge, MA CLIA-certified laboratory.  For more information, please visit the company's Website at www.metamarkgenetics.com.  Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.


'/>"/>
SOURCE Endo Health Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Metamark Genetics Board of Directors Appoints Shawn M. Marcell President and Chief Executive Officer
2. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
3. PipelineRx Announces Telepharmacy Contract with GNYHA Services
4. ANI Pharmaceuticals Announces an Agreement for the Development and Marketing of an Oral Soft Gel Prescription Product with Sofgen Pharmaceuticals
5. Valeant Pharmaceuticals Announces Continuance
6. PatientStream Announces Industry Top Performer, Tom McLaren, to Lead an Exclusive Education Webinar on Surgical Efficiency to 300+ hospitals nationwide.
7. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
8. Northwest Biotherapeutics Announces Registered Direct Offering
9. PDL BioPharma Announces Second Quarter 2013 Financial Results
10. Echo Therapeutics Announces Second Quarter 2013 Financial Results
11. Alere Announces Preliminary Results Of Voting At Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... 18, 2019 , ... Uniform Advantage (UA), a leader in the ... Breast Cancer programs and services. , This year, more than 271,000 Americans will be ... the month of October 2019, Uniform Advantage will donate $5 for every unique use ...
(Date:9/17/2019)... ... September 17, 2019 , ... Scientists writing ... therapeutic agents to stop the progressive destruction of joint cartilage in osteoarthritis are ... Miami-based hand and upper limb orthopedic surgeon Alejandro Badia, MD , founder ...
(Date:9/17/2019)... ... ... Drs. Nickelice Brand and Chris Williams restore smiles of Ocala, FL patients by ... are a nearly permanent, comfortable and efficient way for patients to replace their missing ... placed by highly trained professionals such as Drs. Brand and Williams, providing patients a ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... ... help extend the lives of some cancer patients? In companion presentations at the ... Roswell Park Comprehensive Cancer Center report new evidence that low-dose aspirin and other ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... that he has been certified by the American Academy of Facial Esthetics (AAFE) ... correct a wide range of orofacial conditions such as tooth clenching and grinding, ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... advocacy group BPAN Warriors , with the goal of providing resources to ... Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a progressive disease causing abnormal iron deposits in the ...
(Date:9/17/2019)... ... September 17, 2019 , ... CORE Medical ... Dr. Yevgeniya (Jenny) Gartshteyn to their team of expert physicians. Dr. Gartshteyn completed ... the Clinical Appointment of Assistant Professor in Medicine for the Division of Hospitalist ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... detection and treatment of infectious diseases at its annual Congress (WMIC) recently ... detection of residual HIV infected cell persistence and the development of pathogen-specific ...
Breaking Medicine News(10 mins):